Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Complement factor H and hemolytic uremic syndrome.

P F Zipfel1, C Skerka, J Caprioli

  • 1Department of Infection Biology, Hans Knoell Institute for Natural Products Research, Beutenbergstr. I1a, 07745 Jena, Germany. zipfel@pmail.hki-jena.de

International Immunopharmacology
|May 23, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The C-terminus of complement regulator Factor H mediates target recognition: evidence for a compact conformation of the native protein.

Clinical and experimental immunology·2006
Same author

Deletion of Lys224 in regulatory domain 4 of Factor H reveals a novel pathomechanism for dense deposit disease (MPGN II).

Kidney international·2006
Same author

Variations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease).

Journal of medical genetics·2005
Same author

Haemolytic uraemic syndrome and mutations of the factor H gene: a registry-based study of German speaking countries.

Journal of medical genetics·2003
Same author

Factor H family proteins: on complement, microbes and human diseases.

Biochemical Society transactions·2002
Same author

Further characterization of complement regulator-acquiring surface proteins of Borrelia burgdorferi.

Infection and immunity·2001
Same journal

Flavokawain C alleviates dextran sulphate sodium-induced colitis through suppressing necroptosis via blocking RIPK1-RIPK3-MLKL axis.

International immunopharmacology·2026
Same journal

Comment on: Exploring the mechanism of ropivacaine in alleviating neuropathic pain via the mTOR-PKM2/STAT3-H4K12 lactylation axis.

International immunopharmacology·2026
Same journal

Efficacy and safety of recombinant human thrombopoietin (rhTPO) in critically ill patients with severe thrombocytopenia: A single-center retrospective cohort study.

International immunopharmacology·2026
Same journal

Pramipexole mitigates rotenone-evoked hepatic injury by regulating inflammatory, antioxidant, apoptosis and NLRP3-mediated pyroptosis.

International immunopharmacology·2026
Same journal

CIRBP mediates hypoxia-induced mitochondrial metabolic reprogramming in microglia to regulate polarization and anxiety-like behavior.

International immunopharmacology·2026
Same journal

Vagus nerve stimulation alleviates anxiety by inhibiting ferroptosis-related neuronal damage through α7nAChR.

International immunopharmacology·2026
See all related articles

Factor H deficiency is linked to Hemolytic Uremic Syndrome (HUS). The C-terminal domain (SCR 20) of factor H is critical for regulating complement and preventing HUS.

Area of Science:

  • Biochemistry
  • Immunology
  • Genetics

Background:

  • Factor H is a plasma glycoprotein regulating the complement alternative pathway.
  • Factor H deficiency is associated with various diseases, including HUS.
  • HUS involves microangiopathic hemolytic anemia, thrombocytopenia, and renal failure due to platelet thrombi.

Purpose of the Study:

  • To review genetic and biochemical data on Factor H's role in HUS pathogenesis.
  • To highlight the significance of the C-terminal SCR 20 domain in HUS.
  • To discuss the functional implications of SCR 20 in Factor H's regulatory activities.

Main Methods:

  • Analysis of primary sequence for structural organization.
  • Review of biochemical and genetic studies linking Factor H to diseases.

Related Experiment Videos

  • Examination of novel functional data on SCR 20.

    • Main Results:

    • Factor H deficiency is critically involved in HUS pathogenesis.
    • The C-terminal domain, SCR 20, plays a crucial role in HUS.
    • SCR 20 acts as a central regulatory site for Factor H's functions.

    Conclusions:

    • Factor H, particularly its SCR 20 domain, is essential for preventing HUS.
    • Understanding SCR 20's function provides insights into complement regulation and HUS.
    • Targeting SCR 20 may offer therapeutic strategies for HUS.